The Guardian: Mergers & Acquisitions

SEPTEMBER 14, 2023

British tech firm valued at $52.3bn before highly anticipated flotation on Nasdaq by private owner SoftBank The British chip designer Arm has secured a $52.3bn (£41.9bn) valuation in its initial public offering (IPO), before its highly anticipated return to the stock market in New York on Thursday. Continue reading.

IPO 100

IPO Initial Public Offering Shares Valuation 100

The New York Times: Mergers, Acquisitions and Dive

SEPTEMBER 12, 2023

Softbank’s chief executive, Masayoshi Son, believes the chip design company he bought in 2016 is poised to reap the fruits of the A.I. revolution.

Initial Public Offering 102

Initial Public Offering Mergers and Acquisitions Stock Corporation 102

The Harvard Law School Forum

OCTOBER 19, 2022

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. more…).

M&A 103

M&A IPO Shares Initial Public Offering 103

Growth Business

JULY 11, 2023

3) Aquis Stock Exchange Aquis Stock Exchange , run by NEX, allows businesses to raise capital through Initial Public Offerings (IPOs). >See You can even raise the whole £1m in one go – Monzo did this in 96 seconds back in 2016 through Crowdcube.

Finance 75

Finance Finance Business Debt 75

Cooley M&A

SEPTEMBER 16, 2022

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. 17] This approach was used by LinkedIn, a dual-class company, in its acquisition by Microsoft (announced on June 13, 2016).

M&A 59

M&A IPO Mergers and Acquisitions Shares 59

Cooley M&A

JANUARY 25, 2023

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40